Agios Pharmaceuticals, Inc. AGIO
32.58
(0.32)
(0.97%)
as of 25 Sep
- Market cap
- $2.0B
- P/E
- 0.0×
Follow AGIO
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (34.34%) | (32.82%) | (30.20%) | (27.57%) |
+8 more TTM periods Free account |
|
| (31.89%) | (30.84%) | (27.89%) | (25.26%) | ||
ROIC |
(70.24%) | (79.88%) | (87.12%) | (89.67%) | |
Return on Tangible Assets |
(62.56%) | (53.73%) | (47.41%) | (41.41%) | |
Average Days of Receivables |
74.65 | 89.15 | 71.46 | 40.98 | |
Free Cash Flow per Share |
(6.14) | (6.54) | (6.51) | (7.12) | |
Free Cash Flow |
(365.25) | (384.73) | (377.29) | (414.09) | |
Capital Expenditures |
(4.66) | (4.32) | (4.32) | (4.16) | |
Piotroski F-Score |
3.00 | 3.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(21.94%) | (20.61%) | (18.22%) | (18.32%) | |
Accounts Receivable Turnover |
7.84 | 6.78 | 7.36 | 11.00 | |
Accounts Payable Turnover |
0.46 | 0.48 | 0.36 | 0.31 | |
Inventory Turnover |
0.26 | 0.20 | 0.21 | 0.20 | |
Average Days of Payables |
757.77 | 762.68 | 1,055.88 | 1,246.39 | |
Days of Inventory on Hand |
1,397.88 | 1,946.61 | 1,893.74 | 2,041.99 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
362.78% | 526.80% | 628.44% | 746.33% | |
Selling, General and Administrative Expense of Revenue |
195.99% | 283.21% | 333.68% | 402.69% | |
Share Based Compensation of Revenue |
58.96% | 85.90% | 97.27% | 110.14% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.88 | 0.90 | 0.90 | 1.02 | |
Depreciation/Fixed assets |
(0.03) | (0.16) | (0.19) | (0.54) | |
Capex/Depreciation |
13.50 | 2.50 | 2.14 | 0.72 | |
Revenue per Share |
1.65 | 1.12 | 0.93 | 0.77 | |
Operating CF per Share |
(6.06) | (6.47) | (6.43) | (7.05) | |
Capex per Share |
(0.08) | (0.07) | (0.07) | (0.07) | |
Capex to Sales |
0.05 | 0.07 | 0.08 | 0.09 | |
Net Profit Margin |
(418.24%) | (639.84%) | (764.01%) | (895.86%) |
Columns are period end dates